Learning more about indications for implantable cardioverter-defibrillators

Journal article

Peer reviewed

R J Myerburg and A Castellanos

Journal of the American College of Cardiology, Vol.34(4), pp.1096-1098

1999-10

PMID: 10520796

Abstract

Tachycardia, Ventricular - therapy

Humans

Middle Aged

Ventricular Fibrillation - mortality

Male

Survival Rate

Treatment Outcome

Ventricular Dysfunction, Left - mortality

Hemodynamics - physiology

Anti-Arrhythmia Agents - administration & dosage

Ventricular Dysfunction, Left - physiopathology

Amiodarone - administration & dosage

Amiodarone - adverse effects

Ventricular Dysfunction, Left - therapy

Tachycardia, Ventricular - physiopathology

Tachycardia, Ventricular - mortality

Anti-Arrhythmia Agents - adverse effects

Defibrillators, Implantable

Ventricular Fibrillation - physiopathology

Female

Aged

Hemodynamics - drug effects

Ventricular Fibrillation - therapy

7 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.94 Cardiac Arrhythmia; 1.94.582 Ventricular Tachycardia
Web Of Science research areas: Cardiac & Cardiovascular Systems
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Learning more about indications for implantable cardioverter-defibrillators
Creators: R J Myerburg
A Castellanos
Publication Details: Journal of the American College of Cardiology, Vol.34(4), pp.1096-1098
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Cardiovascular
Language: English
Resource Type: Journal article
PMID: 10520796
Record Identifier: 991031598183702976